Hydrogel-forming microneedle arrays: Potential for use in minimally-invasive lithium monitoring.

We describe, for the first time, hydrogel-forming microneedle (s) (MN) arrays for minimally-invasive extraction and quantification of lithium in vitro and in vivo. MN arrays, prepared from aqueous blends of hydrolysed poly(methyl-vinylether-co-maleic anhydride) and crosslinked by poly(ethyleneglycol), imbibed interstitial fluid (ISF) upon skin insertion. Such MN were always removed intact. In vitro, mean detected lithium concentrations showed no significant difference following 30min MN application to excised neonatal porcine skin for lithium citrate concentrations of 0.9 and 2mmol/l. However, after 1h application, the mean lithium concentrations extracted were significantly different, being appropriately concentration-dependent. In vivo, rats were orally dosed with lithium citrate equivalent to 15mg/kg and 30mg/kg lithium carbonate, respectively. MN arrays were applied 1h after dosing and removed 1h later. The two groups, having received different doses, showed no significant difference between lithium concentrations in serum or MN. However, the higher dosed rats demonstrated a lithium concentration extracted from MN arrays equivalent to a mean increase of 22.5% compared to rats which received the lower dose. Hydrogel-forming MN clearly have potential as a minimally-invasive tool for lithium monitoring in outpatient settings. We will now focus on correlation between serum and MN lithium concentrations.

[1]  Thakur Raghu Raj Singh,et al.  Hydrogel-Forming Microneedle Arrays for Enhanced Transdermal Drug Delivery , 2012, Advanced functional materials.

[2]  J. Aubry,et al.  Lithium: Updated Human Knowledge Using an Evidence-Based Approach , 2009, CNS Drugs.

[3]  Ryan F. Donnelly,et al.  Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[4]  Ryan F. Donnelly,et al.  Microneedle-based drug delivery systems: Microfabrication, drug delivery, and safety , 2010, Drug delivery.

[5]  K. Shulman,et al.  Differential Pharmacokinetics of Lithium in Elderly Patients , 2000, Drugs & aging.

[6]  Maelíosa T. C. McCrudden,et al.  Hydrogel-forming microneedles increase in volume during swelling in skin, but skin barrier function recovery is unaffected. , 2014, Journal of pharmaceutical sciences.

[7]  N. Praschak-Rieder,et al.  Lithium in drinking water and suicide mortality , 2011, British Journal of Psychiatry.

[8]  R. Guy,et al.  Reverse Iontophoresis as a Noninvasive Tool for Lithium Monitoring and Pharmacokinetic Profiling , 2004, Pharmaceutical Research.

[9]  Ryan F. Donnelly,et al.  Design, Optimization and Characterisation of Polymeric Microneedle Arrays Prepared by a Novel Laser-Based Micromoulding Technique , 2010, Pharmaceutical Research.

[10]  P. Das,et al.  Maintaining mood stability in bipolar disorder: a clinical perspective on pharmacotherapy , 2014, Evidence-Based Mental Health.

[11]  Richard H Guy,et al.  Reverse iontophoresis for non-invasive transdermal monitoring. , 2004, Physiological measurement.

[12]  Miss A.O. Penney.  (b) , 1974, The New Yale Book of Quotations.

[13]  U. Häfeli,et al.  Therapeutic drug monitoring in interstitial fluid: a feasibility study using a comprehensive panel of drugs. , 2012, Journal of pharmaceutical sciences.

[14]  Thakur Raghu Raj Singh,et al.  Optical coherence tomography is a valuable tool in the study of the effects of microneedle geometry on skin penetration characteristics and in-skin dissolution. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[15]  Ich Harmonised,et al.  INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE , 2006 .

[16]  W. Shen,et al.  Implication of serum concentration monitoring in patients with lithium intoxication , 2004, Psychiatry and clinical neurosciences.

[17]  J. H. Price,et al.  Influence of plasticizer type and storage conditions on properties of poly(methyl vinyl ether-co-maleic anhydride) bioadhesive films , 2004 .

[18]  J G Hamilton,et al.  Needle phobia: a neglected diagnosis. , 1995, The Journal of family practice.

[19]  N. Oliver,et al.  Use of microneedle array devices for continuous glucose monitoring: a review. , 2013, Diabetes technology & therapeutics.

[20]  R. Schoenwald,et al.  Pharmacokinetics in Drug Discovery and Development , 2002 .

[21]  C Revillard,et al.  [Clinical pharmacokinetics]. , 1976, Schweizerische medizinische Wochenschrift.

[22]  J. McElnay,et al.  Microneedle-Mediated Minimally Invasive Patient Monitoring , 2013, Therapeutic drug monitoring.

[23]  Jung-Hwan Park,et al.  Hydrogel swelling as a trigger to release biodegradable polymer microneedles in skin. , 2012, Biomaterials.

[24]  Ryan F Donnelly,et al.  Dissolving polymeric microneedle arrays for electrically assisted transdermal drug delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[25]  Walter Slavin,et al.  Atomic absorption spectroscopy , 1968 .

[26]  Jung-Hwan Park,et al.  Microneedles for drug and vaccine delivery. , 2012, Advanced drug delivery reviews.

[27]  James D. Campbell,et al.  Needle-free vaccine delivery. , 2006, Advanced drug delivery reviews.

[28]  A. Lund,et al.  Lithium: a review of pharmacology, clinical uses, and toxicity. , 2014, European journal of pharmacology.

[29]  H. McCarthy,et al.  Influence of skin model on in vitro performance of drug-loaded soluble microneedle arrays. , 2012, International journal of pharmaceutics.

[30]  A. Maran,et al.  Non-invasive glucose monitoring: assessment of technologies and devices according to quantitative criteria. , 2007, Diabetes research and clinical practice.

[31]  D. Türck,et al.  Steady-state pharmacokinetics of lithium in healthy volunteers receiving concomitant meloxicam. , 2000, British journal of clinical pharmacology.

[32]  Husseini K. Manji,et al.  Mood-stabilizing drugs: mechanisms of action , 2012, Trends in Neurosciences.

[33]  Ryan F. Donnelly,et al.  A proposed model membrane and test method for microneedle insertion studies , 2014, International journal of pharmaceutics.

[34]  G. Goodwin,et al.  The pharmacokinetic profile of lithium in rat and mouse; An important factor in psychopharmacological investigation of the drug , 1986, Neuropharmacology.

[35]  Richard H Guy,et al.  Lithium monitoring by reverse iontophoresis in vivo. , 2004, Clinical chemistry.

[36]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[37]  A. Kolevzon,et al.  The Pharmacological Treatment of Bipolar Disorder: The Question of Modern Advances , 2010, Harvard review of psychiatry.

[38]  Dale L. Perry,et al.  Handbook of Inorganic Compounds. , 1995 .

[39]  Peter B. Jones,et al.  Lithium in bipolar and other affective disorders: prescribing practice in the UK , 2010, Journal of psychopharmacology.

[40]  A. Fourtanier,et al.  MINIATURE PIG AS AN ANIMAL MODEL TO STUDY PHOTOAGING * , 1988, Photochemistry and photobiology.